NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 126 filers reported holding NUVATION BIO INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,057 | -83.0% | 14,222 | -77.1% | 0.00% | – |
| Q2 2023 | $111,965 | -43.1% | 62,203 | -47.5% | 0.00% | – |
| Q1 2023 | $196,808 | +304.0% | 118,559 | +367.3% | 0.00% | – |
| Q4 2022 | $48,716 | -74.8% | 25,373 | -70.4% | 0.00% | – |
| Q3 2022 | $193,000 | +211.3% | 85,771 | +625.2% | 0.00% | – |
| Q1 2022 | $62,000 | -95.1% | 11,827 | -92.1% | 0.00% | – |
| Q4 2021 | $1,272,000 | +189.1% | 149,570 | +238.2% | 0.00% | – |
| Q3 2021 | $440,000 | -69.8% | 44,219 | -71.8% | 0.00% | – |
| Q2 2021 | $1,459,000 | +321.7% | 156,725 | +372.9% | 0.00% | – |
| Q1 2021 | $346,000 | – | 33,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $120,756,000 | 24.71% |
| Aisling Capital Management LP | 2,541,009 | $13,366,000 | 7.21% |
| EDBI Pte Ltd | 1,270,504 | $6,683,000 | 4.45% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $5,981,000 | 4.43% |
| EcoR1 Capital, LLC | 13,896,543 | $73,096,000 | 2.29% |
| Boxer Capital, LLC | 4,341,009 | $22,834,000 | 1.17% |
| Baupost Group | 10,443,494 | $54,933,000 | 0.59% |
| Redmile Group, LLC | 3,471,709 | $18,261,000 | 0.57% |
| Avidity Partners Management LP | 4,855,006 | $25,537,000 | 0.53% |
| Abrams Capital Management | 3,811,513 | $20,049,000 | 0.47% |